Posted by bleauberry on December 21, 2018, at 7:48:34
In reply to Requip is being discontinued by manufacturer, posted by PeterMartin on December 21, 2018, at 0:38:32
Discontinued because of "business decision"? I don't know. Forgive me for being skeptical. They said the same thing about a failed Lyme vaccine that was actually causing people to get sick with Lyme. They removed it from the market after great protest from patients, extreme protest, but they didn't ever admit it was a lousy drug, they blamed it on "market conditions".
Maybe it's just that other treatments for Parkinsons are doing better.
Dunno. But skeptical. :-)
> Glaxo has made a business decision to no longr make Requip aside from a few hight dose XL versions. Heads up for anyone who takes it.
>
> https://www.empr.com/news/requip-ropinirole-discontinued-supply-glaxosmithkline-parkinson-disease/article/822352/
>
> The Food and Drug Administration (FDA) has posted a discontinuation notice for Requip (ropinirole HCl; GlaxoSmithKline) tablets and certain Requip XL (ropinirole HCl; GlaxoSmithKline) extended-release tablets.
>
> Requip and Requip XL are non-ergot dopamine agonists indicated for the treatment of Parkinson's disease.
>
> The affected products include Requip 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg, and 5mg strength tablets in 100-count bottles, and Requip XL 2mg strength tablets in 30-count bottles. The anticipated final dates of availability to patients are as follows:
>
> Requip 0.25mg (NDC 0007-4890-20): April 2019
> Requip 0.5mg (NDC 0007-4891-20): May 2019
> Requip 1mg (NDC 0007-4892-20): January 2019
> Requip 2mg (NDC 0007-4893-20): January 2019
> Requip 3mg (NDC 0007-4895-20): April 2019
> Requip 4mg (NDC 0007-4896-20): May 2019
> Requip 5mg (NDC 0007-4894-20): March 2019
> Requip XL 2mg (NDC 0007-4885-13): March 2019
> The discontinuation of these products was a business decision, according to the FDA notice. Requip XL is still available as 4mg, 6mg, 8mg, and 12mg extended-release tablets.
poster:bleauberry
thread:1102548
URL: http://www.dr-bob.org/babble/20181024/msgs/1102552.html